<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-4500</journal-id>
<journal-title><![CDATA[Avances en Enfermería]]></journal-title>
<abbrev-journal-title><![CDATA[av.enferm.]]></abbrev-journal-title>
<issn>0121-4500</issn>
<publisher>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-45002024000100002</article-id>
<article-id pub-id-type="doi">10.15446/av.enferm.v42n1.113387</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Calidad de vida en pacientes con trasplante autólogo y alogénico de progenitores hematopoyéticos]]></article-title>
<article-title xml:lang="en"><![CDATA[Quality of life in patients with autologous and allogeneic hematopoietic stem cell transplantation]]></article-title>
<article-title xml:lang="pt"><![CDATA[Qualidade de vida em pacientes submetidos a transplante autólogo e alogénico de células estaminais hematopoiéticas]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López Gómez]]></surname>
<given-names><![CDATA[Alexandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Villa]]></surname>
<given-names><![CDATA[Marjorie]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Clínica Foscal Internacional  ]]></institution>
<addr-line><![CDATA[Floridablanca ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Pontificia Bolivariana  ]]></institution>
<addr-line><![CDATA[Medellín ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2024</year>
</pub-date>
<volume>42</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-45002024000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-45002024000100002&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-45002024000100002&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo comparar la calidad de vida de los pacientes sometidos a trasplante autólogo y alogénico de progenitores hematopoyéticos.  Materiales y método estudio longitudinal analítico con dos mediciones de datos retrospectivos. Se revisaron 188 historias clínicas de pacientes que fueron sometidos a trasplante de progenitores hematopoyéticos. Se diligenció un formulario que indagó por datos sociodemográficos, características clínicas y puntuaciones de la escala de calidad de vida EORTC QLQ-C30.  Resultados la edad promedio de los pacientes fue de 53 años. El 53,2 % era de sexo masculino, y la mayoría de los pacientes (96,3 %) tenían una enfermedad hematológica. Los pacientes con trasplante de células progenitoras hematopoyéticas (TPH) autólogo informaron una mejoría de su estado global de salud, con un puntaje medio de 81,1 ± 16,2, mientras que los pacientes de TPH alogénico desmejoraron, es decir, empeoró su estado global de salud con un puntaje medio de 16,8 ± 17,9 a los 6 meses pos TPH.  Conclusiones la evaluación de la calidad de vida en pacientes que han recibido trasplante autólogo y alogénico de progenitores hematopoyéticos revela desafíos significativos tanto físicos como emocionales en ambos grupos. Los pacientes con trasplante alogénico enfrentan mayores complicaciones debido al riesgo de rechazo y a los efectos del tratamiento inmunosupresor. Por tanto, resulta fundamental implementar un enfoque integral que combine atención multidisciplinar, apoyo psicológico y social para optimizar su bienestar a largo plazo.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective To compare the quality of life of patients undergoing autologous versus allogeneic hematopoietic stem cell transplantation.  Materials and method Analytical longitudinal study conducted with two retrospective data measurements. A total of 188 medical records of patients who underwent hematopoietic stem cell transplantation were reviewed. A data collection form was completed, which inquired about sociodemographic information, clinical characteristics, and scores on the EORTC QLQ-C30 quality of life scale.  Results The average age of the patients was 53 years. Of the total, 53.2% were male, and the majority (96.3%) had a hematological disease. Patients who underwent autologous hematopoietic stem cell transplantation (HSCT) reported an improved perception of their global health status, with a mean score of 81.1 ± 16.2. In contrast, patients who underwent allogeneic HSCT experienced a decrease in their global health status, reporting a mean score of 16.8 ± 17.9 at 6 months post-HSCT, indicating a worsening of their overall health.  Conclusions The assessment of quality of life in patients who have received autologous and allogeneic hematopoietic stem cell transplantation reveals significant physical and emotional challenges in both groups. Patients undergoing allogeneic transplants face greater complications due to the risks of rejection and the effects of immunosuppressive therapy. Therefore, it is essential to implement a comprehensive approach that combines multidisciplinary care with psychological and social support to optimize their long-term well-being.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo comparar a qualidade de vida de pacientes submetidos a transplante autólogo e alogênico de células-tronco hematopoiéticas.  Materiais e método estudo longitudinal analítico com duas medições retrospectivas de dados. Foram analisados 188 registos médicos de doentes submetidos a transplante de células estaminais hematopoiéticas. Foi preenchido um formulário com dados sociodemográficos, características clínicas e pontuação na escala de qualidade de vida EORTC QLQ-C30.  Resultados a média de idade dos pacientes foi de 53 anos, 53,2 % eram do sexo masculino, a maioria dos doentes (96,3 %) tinha uma doença hematológica. Os doentes com TCTH autólogo referiram uma melhoria da perceção do seu estado de saúde global, com uma pontuação média de 81,1 ± 16,2, enquanto os doentes com TCTH alogénico apresentaram uma diminuição, ou seja, um agravamento do estado de saúde global, com uma pontuação média de 16,8 ± 17,9 aos 6 meses após o TCTH.  Conclusões a avaliação da qualidade de vida em doentes submetidos a transplante de células estaminais hematopoiéticas autólogo e alogénico revela desafios físicos e emocionais significativos em ambos os grupos. Os doentes de transplante alogénico enfrentam maiores complicações devido ao risco de rejeição e aos efeitos do tratamento imunossupressor. Por conseguinte, é essencial implementar uma abordagem abrangente que combine cuidados multidisciplinares e apoio psicológico e social para otimizar o seu bem-estar a longo prazo.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Calidad de Vida]]></kwd>
<kwd lng="es"><![CDATA[Enfermedades Hematológicas]]></kwd>
<kwd lng="es"><![CDATA[Trasplante de Células Madre]]></kwd>
<kwd lng="es"><![CDATA[Trasplante Autólogo]]></kwd>
<kwd lng="es"><![CDATA[Trasplante Homólogo]]></kwd>
<kwd lng="en"><![CDATA[Quality of Life]]></kwd>
<kwd lng="en"><![CDATA[Hematologic Diseases]]></kwd>
<kwd lng="en"><![CDATA[Stem Cell Transplantation]]></kwd>
<kwd lng="en"><![CDATA[Transplantation, Autologous]]></kwd>
<kwd lng="en"><![CDATA[Transplantation, Homologous]]></kwd>
<kwd lng="pt"><![CDATA[Qualidade de Vida]]></kwd>
<kwd lng="pt"><![CDATA[Doenças Hematológicas]]></kwd>
<kwd lng="pt"><![CDATA[Transplante de Células-Tronco]]></kwd>
<kwd lng="pt"><![CDATA[Transplante Autólogo]]></kwd>
<kwd lng="pt"><![CDATA[Transplante Homólogo]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>[1]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez-Reyes]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Chandel]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer metabolism: Looking forward]]></article-title>
<source><![CDATA[Nat. Rev. Cancer]]></source>
<year>2021</year>
<volume>21</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>669-80</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>[2]</label><nlm-citation citation-type="">
<collab>World Health Organization</collab>
<source><![CDATA[Cancer today. Data visualization tools for exploring the global cancer burden in 2022]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>[3]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Echeverry]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Dalton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hematologic disorders]]></article-title>
<source><![CDATA[Anesthesiol. Clin]]></source>
<year>2018</year>
<volume>36</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>553-65</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>[4]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amouzegar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dey]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Spitzer]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peripheral blood or bone marrow stem cells? Practical considerations in hematopoietic stem cell transplantation]]></article-title>
<source><![CDATA[Transfus. Med. Rev]]></source>
<year>2019</year>
<volume>33</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-50</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>[5]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haltalli]]></surname>
<given-names><![CDATA[MLR]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkinson]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez-Fraticelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Porteus]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hematopoietic stem cell gene editing and expansion: State of the art technologies and recent applications]]></article-title>
<source><![CDATA[Exp. Hematol]]></source>
<year>2022</year>
<volume>107</volume>
<page-range>9-13</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>[6]</label><nlm-citation citation-type="">
<collab>American Cancer Society</collab>
<source><![CDATA[El proceso de un trasplante de células madre o médula ósea]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B7">
<label>[7]</label><nlm-citation citation-type="">
<collab>Fundación Josep Carreras contra la leucemia</collab>
<source><![CDATA[El trasplante de progenitores hematopoyéticos]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>[8]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Inamoto]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Late effects of blood and marrow transplantation]]></article-title>
<source><![CDATA[Haematologica]]></source>
<year>2017</year>
<volume>102</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>614-25</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>[9]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balassa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Danby]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Rocha]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Haematopoietic stem cell transplants: Principles and indications]]></article-title>
<source><![CDATA[Br J Hosp Med]]></source>
<year>2019</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>[10]</label><nlm-citation citation-type="book">
<collab>Instituto Nacional de Salud</collab>
<source><![CDATA[Informe anual 2021. Red de donación y trasplantes Colombia]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Bogotá, Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Instituto Nacional de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>[11]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cáceres-Manrique]]></surname>
<given-names><![CDATA[F de M]]></given-names>
</name>
<name>
<surname><![CDATA[Parra-Prada]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Pico-Espinosa]]></surname>
<given-names><![CDATA[OJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida relacionada con la salud en población general de Bucaramanga, Colombia]]></article-title>
<source><![CDATA[Rev. salud pública]]></source>
<year>2018</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>147-54</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>[12]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[E-K]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[I-R]]></given-names>
</name>
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jang]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Comparison of quality of life and depression between hematopoietic stem cell transplantation survivors and their spouse caregivers]]></article-title>
<source><![CDATA[Blood Res]]></source>
<year>2019</year>
<volume>54</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>137-43</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>[13]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xing]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Bai]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Qian]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Are spiritual interventions beneficial to patients with cancer? A meta-analysis of randomized controlled trials following Medicine]]></article-title>
<source><![CDATA[Medicine]]></source>
<year>2018</year>
<volume>97</volume>
<numero>35</numero>
<issue>35</issue>
<page-range>e11948</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>[14]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amado-Tineo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Apolaya Segura]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Che Hidalgo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas-Tineo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Solis Sarmiento]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Oscanoa Espinoza]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life in patients with advanced cancer according to place of care in a referral hospital]]></article-title>
<source><![CDATA[Rev. Fac. Med. Hum]]></source>
<year>2021</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>138-44</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>[15]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baum]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lax]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lehmann]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Merkel-Jens]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Beelen]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Jöckel]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impairment of vocational activities and financial problems are frequent among German blood cancer survivors]]></article-title>
<source><![CDATA[Sci. Rep]]></source>
<year>2023</year>
<volume>13</volume>
<numero>22856</numero>
<issue>22856</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>[16]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodas Mosquera]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida percibida por pacientes oncológicos en estadio y IV, del Hospital José Carrasco Arteaga. Cuenca. 2018]]></article-title>
<source><![CDATA[Rev. Fac. Cienc. Médic. Univ. Cuenca]]></source>
<year>2020</year>
<volume>38</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>23-32</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>[17]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Booker]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[McLennan]]></surname>
</name>
<name>
<surname><![CDATA[Beattie]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Stajduhar]]></surname>
<given-names><![CDATA[KI]]></given-names>
</name>
<name>
<surname><![CDATA[Sawatzky]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Integrating palliative care in hematopoietic stem cell transplantation: A qualitative study exploring patient, caregiver, and clinician perspectives]]></article-title>
<source><![CDATA[Oncol. Nurs. Forum]]></source>
<year>2023</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>313-23</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>[18]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morales Rodríguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo Calvo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Granado-Peinado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Bilbao]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[San Juan]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of exercise programs on psychoemotional and quality-of-life factors in adult patients with cancer and hematopoietic stem cell transplantation or bone marrow transplantation: A systematic review]]></article-title>
<source><![CDATA[Int. j. environ. res. public health]]></source>
<year>2022</year>
<volume>19</volume>
<numero>23</numero>
<issue>23</issue>
<page-range>15896</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>[19]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Marques A da CB]]></surname>
</name>
<name>
<surname><![CDATA[da Silva]]></surname>
<given-names><![CDATA[LAA]]></given-names>
</name>
<name>
<surname><![CDATA[Koller]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[Kalinke]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cognitive impairment and quality of life of patients subjected to hematopoietic stem cell transplantation]]></article-title>
<source><![CDATA[Aquichan]]></source>
<year>2021</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e2126</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>[20]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Megari]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Instrumental activities of daily living and neuropsychological functioning among patients with different types of cancer]]></article-title>
<source><![CDATA[Eur J Neurol]]></source>
<year>2021</year>
<volume>28</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>66-70</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>[21]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Waehrens]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Brandt]]></surname>
<given-names><![CDATA[Å]]></given-names>
</name>
<name>
<surname><![CDATA[Peoples]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Cour]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Everyday activities when living at home with advanced cancer: A cross-sectional study]]></article-title>
<source><![CDATA[Eur J Cancer Care (Engl)]]></source>
<year>2020</year>
<volume>29</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>e13258</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>[22]</label><nlm-citation citation-type="">
<collab>Clínica FOSCAL</collab>
<source><![CDATA[Santander: FOSCAL Internacional]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B23">
<label>[23]</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez Polanco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rúa Lizárraga]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<source><![CDATA[Propiedades psicométricas del cuestionario de calidad de vida QLQ-C30 en pacientes oncológicos]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Lima, Perú ]]></publisher-loc>
<publisher-name><![CDATA[Universidad San Ignacio de Loyola]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>[24]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez-Pedraza]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Valderamar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación para utilización en Colombia de la escala EORTC QLQ C-30 para evaluación de la calidad de vida de los pacientes con cáncer]]></article-title>
<source><![CDATA[Rev. colomb. cancerol]]></source>
<year>2020</year>
<volume>24</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>61-71</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>[25]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Husson]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[de Rooij]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Kieffer]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Oerlemans]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mols]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Aaronson]]></surname>
<given-names><![CDATA[NK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The EORTC QLQ&#8208;C30 summary score as prognostic factor for survival of patients with cancer in the "Real-World": Results from the population&#8208;based registry]]></article-title>
<source><![CDATA[Oncologist]]></source>
<year>2020</year>
<volume>25</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e722-32</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>[26]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machingura]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taye]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Musoro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Flechtner]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bottomley]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study]]></article-title>
<source><![CDATA[Eur. J. Cancer]]></source>
<year>2022</year>
<volume>170</volume>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>[27]</label><nlm-citation citation-type="book">
<collab>European Organisation for Research and Treatment of Cancer</collab>
<source><![CDATA[EORTC QLQ-C30 Scoring Manual]]></source>
<year>2001</year>
<edition>Third edition</edition>
<publisher-loc><![CDATA[Brussels, Bélgica ]]></publisher-loc>
<publisher-name><![CDATA[EORTC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B28">
<label>[28]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Proença S de FFS]]></surname>
</name>
<name>
<surname><![CDATA[Marques A da CB]]></surname>
</name>
<name>
<surname><![CDATA[Mantovani M de F]]></surname>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[Kalinke]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida de los pacientes sometidos al trasplante de células madre autólogo y alogénico en la hospitalización]]></article-title>
<source><![CDATA[Enferm. glob]]></source>
<year>2018</year>
<volume>17</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>401-45</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>[29]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mosher]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Redd]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Rini]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Burkhalter]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[DuHamel]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: A review of the literature]]></article-title>
<source><![CDATA[Psycho-Oncology]]></source>
<year>2009</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>113-27</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>[30]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ríos-Quezada]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Cruzat-Mandich]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Percepción y significados asociados a la calidad de vida en pacientes hemato-oncológicos]]></article-title>
<source><![CDATA[Rev. chil. neuro-psiquiatr]]></source>
<year>2015</year>
<volume>53</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>261-8</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>[31]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[You]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cong]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A retrospective comparison of allogenic and autologous hematopoietic stem cell transplantation in patients with T-Cell lymphoblastic lymphoma]]></article-title>
<source><![CDATA[Blood]]></source>
<year>2023</year>
<volume>142</volume>
<numero>Supplement 1</numero>
<issue>Supplement 1</issue>
<page-range>7112</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>[32]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marques A da CB]]></surname>
</name>
<name>
<surname><![CDATA[Szczepanik]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[PND]]></given-names>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[Kalinke]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hematopoietic stem cell transplantation and quality of life during the first year of treatment]]></article-title>
<source><![CDATA[Rev. Lat.-Am. Enferm]]></source>
<year>2018</year>
<volume>26</volume>
<numero>e3065</numero>
<issue>e3065</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>[33]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Marques A da CB]]></surname>
</name>
<name>
<surname><![CDATA[Nogueira L de A]]></surname>
</name>
<name>
<surname><![CDATA[Lenhani]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Felix]]></surname>
<given-names><![CDATA[JVC]]></given-names>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life and changes in the social dimension of hematopoietic stem cell transplants recipients]]></article-title>
<source><![CDATA[Rev. Bras. Enferm]]></source>
<year>2021</year>
<volume>74</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e20200644</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>[34]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shahrour]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chicaiza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Omar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Bovbjerg]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Stanton]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Greater social isolation and social constraints prior to hematopoietic stem cell transplant are associated with greater anxiety and depressive symptoms]]></article-title>
<source><![CDATA[Int. J. Behav. Med]]></source>
<year>2023</year>
<volume>31</volume>
<page-range>341-51</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>[35]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of quality of life and its influencing factors after transplantation of leukemia patients based on SF-36 score: a cohort study]]></article-title>
<source><![CDATA[Qual Life Res]]></source>
<year>2020</year>
<volume>29</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1809-16</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>[36]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[dos Santos]]></surname>
<given-names><![CDATA[CLT]]></given-names>
</name>
<name>
<surname><![CDATA[Sawada]]></surname>
<given-names><![CDATA[NO]]></given-names>
</name>
<name>
<surname><![CDATA[dos Santos]]></surname>
<given-names><![CDATA[JLF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of the health-related quality of life of hematopoietic stem cell transplantation patients]]></article-title>
<source><![CDATA[Rev. Lat.-Am. Enferm]]></source>
<year>2011</year>
<volume>19</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1322-8</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>[37]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marques A da CB]]></surname>
</name>
<name>
<surname><![CDATA[Machado]]></surname>
<given-names><![CDATA[CAM]]></given-names>
</name>
<name>
<surname><![CDATA[Tomim]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Guimarães]]></surname>
<given-names><![CDATA[PRB]]></given-names>
</name>
<name>
<surname><![CDATA[Felix]]></surname>
<given-names><![CDATA[JVC]]></given-names>
</name>
<name>
<surname><![CDATA[Kalinke]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluación de la calidad de vida después de tres años del trasplante de células madre hematopoyéticas]]></article-title>
<source><![CDATA[Rev. esc. enferm]]></source>
<year>2021</year>
<volume>55</volume>
<page-range>e20200270</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>[38]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brice]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gilroy]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Dyer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Masura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Greenwood]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Larsen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Haematopoietic stem cell transplantation survivorship and quality of life: Is it a small world after all?]]></article-title>
<source><![CDATA[Support Care Cancer]]></source>
<year>2017</year>
<volume>25</volume>
<page-range>421-7</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>[39]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurosawa]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Oshima]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Yamaguchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kanda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Okamoto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Atsuta]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease]]></article-title>
<source><![CDATA[Biol Blood Marrow Transplant]]></source>
<year>2017</year>
<volume>23</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1749-58</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>[40]</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cazón]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Educación del paciente adulto en trasplante de células progenitoras hematopoyéticas]]></article-title>
<source><![CDATA[Notas enferm]]></source>
<year>2022</year>
<volume>22</volume>
<numero>39</numero>
<issue>39</issue>
<page-range>23-32</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
